Comments on: Pfizer gets rights to 55 generic pills, 20 injectibles through new deals http://www.dancewithshadows.com/pillscribe/pfizer-gets-rights-to-55-generic-pills-20-injectibles-through-new-deals/ The best of pharma news and views Wed, 28 Jul 2010 09:17:36 +0000 hourly 1 http://wordpress.org/?v=3.1 By: GSK-Dr Reddy's generic drugs pact for supplying branded generics to emerging markets | DWS Pill Scribe http://www.dancewithshadows.com/pillscribe/pfizer-gets-rights-to-55-generic-pills-20-injectibles-through-new-deals/comment-page-1/#comment-1591 GSK-Dr Reddy's generic drugs pact for supplying branded generics to emerging markets | DWS Pill Scribe Fri, 19 Jun 2009 18:43:28 +0000 http://www.dancewithshadows.com/pillscribe/?p=580#comment-1591 [...] Under the terms of the agreement, Pfizer has acquired rights to 55 solid oral dose products and 20 sterile injectable products for patients in more than 70 emerging market countries in Latin America, Eastern Europe, Asia, Africa and the Middle East. Related story: Pfizer gets rights to 55 generics [...] [...] Under the terms of the agreement, Pfizer has acquired rights to 55 solid oral dose products and 20 sterile injectable products for patients in more than 70 emerging market countries in Latin America, Eastern Europe, Asia, Africa and the Middle East. Related story: Pfizer gets rights to 55 generics [...]

]]> By: Hardik http://www.dancewithshadows.com/pillscribe/pfizer-gets-rights-to-55-generic-pills-20-injectibles-through-new-deals/comment-page-1/#comment-361 Hardik Fri, 22 May 2009 05:56:43 +0000 http://www.dancewithshadows.com/pillscribe/?p=580#comment-361 Hi just happened to read your post and delighted to know that there is someone over the web who is dedicatedly tracking the pharma industry and publishing ONLY for this new medium. pharma is a wide and dynamic space and getting up-to-date, detailed information at one source is difficult. I handle PR for Lupin and in this case, would love to have a more detailed conversation with you w.r.t. the pharma industry - to get an understanding of a few terms from a layman's perspective. Look forward to hearing from you. Thanks, Hardik Hi

just happened to read your post and delighted to know that there is someone over the web who is dedicatedly tracking the pharma industry and publishing ONLY for this new medium.

pharma is a wide and dynamic space and getting up-to-date, detailed information at one source is difficult. I handle PR for Lupin and in this case, would love to have a more detailed conversation with you w.r.t. the pharma industry – to get an understanding of a few terms from a layman’s perspective.

Look forward to hearing from you.

Thanks,
Hardik

]]>